Image: SITEASSETS MEDICARE HERO MEDICARE

For Your Medicare Part B Patients – getting
CONTOUR®NEXT products should never be difficult:

1

Choose the CONTOUR®NEXT Portfolio Blood Glucose Meter that works best for you.

CONTOUR®NEXT EZ

  • Proven accuracy1- shown to deliver results within ±10% of lab values
  • Large, easy-to-read display - ready to test right out of the box
  • Small blood sample
  • Second-Chance® sampling - gives patients up to 20 seconds to reapply blood to the same strip which may help prevent wasted strips3

CONTOUR®NEXT ONE

  • Remarkable accuracy2 - shown to deliver results within ±8.4% of lab values
  • Easy-to-read - display with smartLIGHT feature gives you instant feedback with colored target indicators
  • Small blood sample


WITHIN
TARGET
ABOVE
TARGET
BELOW
TARGET
  • Second-Chance® sampling - gives patients up to 60 seconds to reapply blood to the same strip which may help prevent wasted strips3

2

Write a Medicare Part B prescription for CONTOUR®NEXT.

To avoid callbacks and ensure your patient receives the CONTOUR®NEXT Brand:

  • Write the exact brand (CONTOUR®NEXT) of the product to avoid confusion or substitution
  • Write "DO NOT SUBSTITUTE" on the prescription
  • If the prescription is denied, check that the pharmacy ran Medicare Part B.

Remember, CONTOUR®NEXT Test Strips are always covered under Medicare Part B!*

3

Direct your patients to their pharmacy for fulfillment of their CONTOUR®NEXT prescription.

Need more help? Here are answers to some frequently asked questions about Medicare coverage:
 

This is for informational purposes only. Please visit www.medicare.gov to learn more about Medicare plans and coverage.

Test strips are covered when medically necessary and prescribed by a physician. Medicare will reimburse either 80% of the Medicare Fee Schedule or the actual charges, whichever is less.

  • This means that once the annual Medicare "Part B" deductible is paid, patients pay the other 20%. If they have supplemental or secondary insurance, they may pay even less than the 20%.
  • Many pharmacies, mail order and medical equipment suppliers will take care of all the Medicare paperwork and billing submissions.
  • Patients should ask the pharmacist if this service is offered before they buy their CONTOUR®NEXT test strips.

More questions about Medicare?
Learn more about Medicare plans and coverage at: https://www.medicare.gov/pubs/11022-Medicare-Diabetes-Coverage.pdf

This is for informational purposes only. Please visit www.medicare.gov to learn more about Medicare plans and coverage.

CONTOUR®  NEXT Test Strips

For non-insulin treated patients

  • 100 every 3 months

For insulin treated patients

  • 100 per month

Important note:
Medicare allows additional test strips and lancets if deemed medically necessary. See LMN Matters SE1008 for more information: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNMattersArticles/downloads/SE1008.pdf

  • You must provide your patient with a prescription in order to obtain Medicare reimbursement.
  • Remember to specify "Do Not Substitute" on the prescription to ensure that your patient receives the CONTOUR®NEXT brand.
  • Patients can take their prescription to their local pharmacy, hospital or clinic pharmacy, medical equipment supplier, or Medicare mail order contract supplier.
  • Your patients may want to call their chosen supplier to ensure that they sell CONTOUR®NEXT test strips and that they will assist in filing their claim.

If your patients have any difficulty in obtaining their CONTOUR®NEXT test strips please call us (1-800-348-8100) and we will help them find a Medicare supplier who will provide them with CONTOUR®NEXT test strips.

To find a supplier that’s enrolled in Medicare, visit www.medicare.gov/supplier or call 1-800-MEDICARE (1-800-633-4227) .




†10% applies to glucose levels ≥100 mg/dL. In multiple clinical trials examined by Bernstein et al., the CONTOUR®NEXT meter portfolio delivered at least 95% of results within 10% of the laboratory reference value for blood glucose concentrations ≥100 mg/dL and within ±10 mg/dL of the laboratory reference value for blood glucose concentrations <100 mg/dL.

‡ ±8.4% applies to values ≥100mg/dL. An ad hoc analysis demonstrated 95% of results fell within ±8.4 mg/dL or ±8.4% of the laboratory reference values for glucose concentrations <100 mg/dL or ≥100 mg/dL, respectively, when tested via subject-obtained capillary fingertip results (patients with diabetes).

*Not a guarantee of coverage and payment. A doctor’s prescription is required for Medicare coverage and patients must meet Medicare eligibility coverage criteria. Coverage and payment may be subject to coinsurance, deductible and patient eligibility requirements. Visit http://www.medicare.gov to learn more about Medicare plans and coverage.

References: 1. Bernstein, R. et al. A new test strip technology platform for self-monitoring of blood glucose. Journal of Diabetes Science and Technology. 2013; 7(5):1386-1399. 2. Christiansen, M. et al. A New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device: Accuracy and User Performance Evaluation. Journal of Diabetes Science and Technology. 2017, Vol. 11(3) 567-573.3. Ascensia Diabetes Care. Data on File. Market Research, Hall & Partners, conducted online April/May 2015

The information brought to you by Ascensia Diabetes Care US Inc. provides general information and is not a guarantee of coverage or payment (partial or full), and is not intended as medical advice, diagnosis or treatment. Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures.

©2020 Ascensia Diabetes Care US Inc. All rights reserved.